AKT1 and type 2 diabetes mellitus: However, further studies are needed to better understand the specific effects of GPF on the mechanisms involved in the development and progression of T2DM, including glucose transporters and the insulin signaling pathway, including IRS-1, PI3K, AKT, and GSK-3β.